Hematology

A study analysing data from the US Renal Data System has revealed a significant risk of pulmonary embolism in patients with end-stage kidney disease starting dialysis…

A new study accessed the Mayo Clinic database to investigate the long-term survival of patients with myeloproliferative neoplasms and acute myeloid leukaemia associated with multihit TP53 mutations…

Researchers have developed the ALA-CART platform to enhance CAR T cell therapy’s effectiveness against antigen-low leukemias.

A new study shows that GLP-1 receptor agonists (GLP-1RAs) could significantly reduce the risk of developing hematologic cancers in patients with Type 2 diabetes.

A study of 783 patients in 38 T cell therapy trials reveals reassuring results about the long-term safety of gene therapies for HIV-1 and cancer, with only 2.3% developing secondary malignancies.

Universal genetic testing for haemoglobinopathies can enhance early detection and health equity in newborn screening programmes worldwide.

CAR T-cell therapy for B-cell lymphoma shows a positive long-term safety profile with few late complications.

Recent research highlights the significant underuse of disease-modifying therapies for sickle cell disease, despite their established benefits in reducing pain and preventing organ damage.